Vanguard Personalized Indexing Management LLC increased its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 22.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 38,771 shares of the company's stock after buying an additional 6,997 shares during the quarter. Vanguard Personalized Indexing Management LLC's holdings in HCA Healthcare were worth $14,854,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Concurrent Investment Advisors LLC increased its holdings in HCA Healthcare by 4.3% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 2,235 shares of the company's stock worth $856,000 after buying an additional 93 shares during the period. Apollon Wealth Management LLC increased its holdings in HCA Healthcare by 58.0% in the 2nd quarter. Apollon Wealth Management LLC now owns 5,716 shares of the company's stock worth $2,190,000 after buying an additional 2,098 shares during the period. Fifth Third Wealth Advisors LLC grew its stake in shares of HCA Healthcare by 25.0% during the 2nd quarter. Fifth Third Wealth Advisors LLC now owns 2,009 shares of the company's stock worth $770,000 after purchasing an additional 402 shares during the period. PDS Planning Inc grew its stake in shares of HCA Healthcare by 12.9% during the 2nd quarter. PDS Planning Inc now owns 1,260 shares of the company's stock worth $483,000 after purchasing an additional 144 shares during the period. Finally, Monument Capital Management acquired a new stake in shares of HCA Healthcare during the 2nd quarter worth approximately $234,000. Institutional investors and hedge funds own 62.73% of the company's stock.
Insider Activity
In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the firm's stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company's stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.30% of the stock is owned by company insiders.
Analysts Set New Price Targets
HCA has been the topic of a number of analyst reports. Barclays raised their price objective on shares of HCA Healthcare from $390.00 to $445.00 and gave the stock an "overweight" rating in a research note on Thursday, September 18th. Wolfe Research lowered HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. Bank of America increased their target price on HCA Healthcare from $375.00 to $410.00 and gave the company a "neutral" rating in a research report on Wednesday, September 10th. Robert W. Baird increased their target price on HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a research report on Thursday, August 14th. Finally, Morgan Stanley decreased their target price on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research report on Monday, July 28th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average price target of $422.31.
Get Our Latest Research Report on HCA Healthcare
HCA Healthcare Stock Performance
Shares of HCA stock opened at $414.73 on Friday. The stock's fifty day moving average is $405.12 and its two-hundred day moving average is $375.85. The firm has a market capitalization of $97.04 billion, a P/E ratio of 17.43, a PEG ratio of 1.31 and a beta of 1.40. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $439.01.
HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the firm posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.
HCA Healthcare Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were paid a $0.72 dividend. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.
HCA Healthcare Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Read More
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.